Abstract

Scleroderma is a rare heterogenous group of autoimmune fibrosing disorder that mainly exists in two forms; localized scleroderma (LS) and systemic sclerosis (SSc). It involves thickening of the skin at fingers region extending from proximal to metacarpophalangeal joints. The diagnostic criteria of scleroderma include past history of patient, symptoms of patient, serology, and skin biopsy. The morbidity and mortality are much worse for SSc with the patients are at risk for life threatening lung, heart and other visceral organ fibrosis and vasculopathy. There is no drug that can cure or stop scleroderma over fibrosis, but certain drugs regulate the symptoms associated with it and boost the patient's quality of life, particularly steroidal creams that help alleviate swelling, joint pain, loosen tight skin; blood pressure drugs that dilate blood vessels; immunosuppressive agents. If the disease is severe amputation is necessary.

Highlights

  • Scleroderma is an autoimmune, rheumatic, chronic disease that affects tissues by changing the connective tissue

  • A male patient of age 34 years and weight about 65kgs with chief complaints of arthralgia, digital pitting, sleep disturbances, paresthesia, Raynaud’s, calcinosis, vitals pulse rate and temperature was found to be normal, BP-128/96 mm of hg,and systemic examination was fond to be normal based on signs and symptoms and lab data the patient is diagnosed as sarcoderma and recommended the following medications Tab

  • Scleroderma is an autoimmune disease in which the autoantibodies produced will be targeting blood vessels and connective tissues[10]

Read more

Summary

A Case Report on Scleroderma: A Diagnostic Dilema

Anjana Male1*, Hari Chandana Varikallu, Tirumalasetty Sai Swapna, N. This work was carried out in collaboration among all authors. All authors read and approved the final manuscript. (1) Dr Mohamed Fawzy Ramadan Hassanien, Zagazig University, Egypt.

INTRODUCTION
CASE REPORT
Cancer and Scleroderma
Pathogenesis of scleroderma
Treatment Options
CONCLUSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call